| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |